Literature DB >> 30191021

Hepatocellular carcinoma: asphyxiate and then cook.

Philippe Kolly1,2,1,2, Jean-François Dufour1,2,1,2.   

Abstract

Entities:  

Keywords:  HCC; RFA; TACE; ablation; chemoembolization

Year:  2015        PMID： 30191021      PMCID： PMC6095311          DOI： 10.2217/hep.15.31

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  20 in total

Review 1.  Loco-regional treatment of hepatocellular carcinoma.

Authors:  Riccardo Lencioni
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

2.  Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?

Authors:  Toshiya Shibata; Hiroyoshi Isoda; Yusuke Hirokawa; Shigeki Arizono; Kotaro Shimada; Kaori Togashi
Journal:  Radiology       Date:  2009-06-30       Impact factor: 11.105

3.  Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.

Authors:  Manabu Morimoto; Kazushi Numata; Masaaki Kondou; Akito Nozaki; Satoshi Morita; Katsuaki Tanaka
Journal:  Cancer       Date:  2010-07-29       Impact factor: 6.860

4.  Medium-sized (3.1-5.0 cm) hepatocellular carcinoma: transarterial chemoembolization plus radiofrequency ablation versus radiofrequency ablation alone.

Authors:  Jin Hyoung Kim; Hyung Jin Won; Yong Moon Shin; Sung Hee Kim; Hyun-Ki Yoon; Kyu-Bo Sung; Pyo Nyun Kim
Journal:  Ann Surg Oncol       Date:  2011-03-29       Impact factor: 5.344

5.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

Review 6.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Authors:  Calogero Cammà; Filippo Schepis; Ambrogio Orlando; Maddalena Albanese; Lillian Shahied; Franco Trevisani; Pietro Andreone; Antonio Craxì; Mario Cottone
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

Review 7.  Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions.

Authors:  Luigi Bolondi; Andrew Burroughs; Jean-François Dufour; Peter R Galle; Vincenzo Mazzaferro; Fabio Piscaglia; Jean Luc Raoul; Bruno Sangro
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

8.  Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.

Authors:  Zhen-Wei Peng; Yao-Jun Zhang; Min-Shan Chen; Li Xu; Hui-Hong Liang; Xiao-Jun Lin; Rong-Ping Guo; Ya-Qi Zhang; Wan Yee Lau
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

Review 9.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.